SARS News and Research

RSS

Pacific oyster as a weapon against SARS-CoV-2

According to an article published in the journal Reviews in Medical Virology, the effectiveness of mollusc-derived antiviral agents has been proven in many different laboratory and animal studies, while its efficacy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been proposed by recent in silico studies.

7 Nov 2021

New data points to major SARS-CoV-2 animal reservoir in deer in Iowa

A new study tests the hypothesis that white-tailed deer are susceptible to SARS-CoV-2 infection.

7 Nov 2021

Reducing airborne transmission of infectious respiratory viruses with portable air purifiers

A new computational study focuses on the performance of portable air purifiers based on Computational Fluid Dynamics (CFD) simulations.

7 Nov 2021

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

A new study proposed that the RNA structure and the genome component may serve as an important basis of different deamination spectrums in SARS-CoV-2.

7 Nov 2021

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.

7 Nov 2021

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

A new study describes a new small molecule compound that has shown impressive safety, tolerability, and bioavailability against SARS-CoV-2.

7 Nov 2021

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

A recent study assesses the boost in antibodies against SARS-CoV-2)variants post-vaccination in plasma samples from previously infected COVID-19 patients.

7 Nov 2021

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

7 Nov 2021

New type of COVID vaccine potentially easier to produce and does not need refrigeration

Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries.

6 Nov 2021

Scientists create a rapid diagnostic technology to detect SARS-CoV-2

Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2, the coronavirus that causes COVID-19.

6 Nov 2021

Researchers use suction method to deliver SARS-CoV-2 DNA vaccine in lab tests

Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.

6 Nov 2021

Study uncovers a process in cells that may limit infectivity of SARS-CoV-2

Scientists at the National Institutes of Health have found that a process in cells may limit infectivity of SARS-CoV-2, and that mutations in the alpha and delta variants overcome this effect, potentially boosting the virus's ability to spread.

6 Nov 2021

Study finds benefits of COVID vaccination in pregnancy outweighs risks

A new preprint explores the efficacy of vaccination against infection with SARS-CoV-2 in pregnancy.

4 Nov 2021

Pfizer COVID-19 vaccine elicits durable specific memory T-cell response

A new preprint describes the protective efficacy of memory T-cells developed in response to the viral antigen, which could offer long-term immunity.

4 Nov 2021

“Catching SARS-CoV-2 in the act” – viral infection of nasal mucosa spares nerve cells

A new study discusses the entry of SARS-CoV-2 into the respiratory and olfactory mucosa of the nasal cavity.

4 Nov 2021

Study shows most young Australians are willing to be tested for COVID

A new study explores the success of testing efforts among children and adolescents in Australia.

4 Nov 2021

Cuba reports 92.4 percent efficacy for 3 dose SOBERANA 02 COVID-19 vaccine

A new study describes the results of the safety and efficacy phase trials of a new COVID-19 vaccine from Cuba.

4 Nov 2021

Aptamer Group and DeepVerge expand partnership for Optimer-enabled wastewater monitoring

Aptamer Group Ltd., the developer of Optimer® binders to enable innovation in the life science industry, is pleased to announce the expansion of its existing partnership with DeepVerge PLC.

4 Nov 2021

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

A team of scientists has recently developed an allele-specific probe polymerase chain reaction method that can accurately detect different variants/lineages of SARS-CoV-2 in respiratory samples.

4 Nov 2021

Murine hepatitis virus as a surrogate for studying SARS-CoV-2 in food processing biofilms

Researchers from Texas A&M University inoculated MHV (SARS-CoV-2 surrogate) into a meat processing environmental biofilm and developed it on stainless steel (SS), PVC, and tiles at 7°C.

4 Nov 2021

SARS News and Research

Pacific oyster as a weapon against SARS-CoV-2

New data points to major SARS-CoV-2 animal reservoir in deer in Iowa

Reducing airborne transmission of infectious respiratory viruses with portable air purifiers

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

New type of COVID vaccine potentially easier to produce and does not need refrigeration

Scientists create a rapid diagnostic technology to detect SARS-CoV-2

Researchers use suction method to deliver SARS-CoV-2 DNA vaccine in lab tests

Study uncovers a process in cells that may limit infectivity of SARS-CoV-2

Study finds benefits of COVID vaccination in pregnancy outweighs risks

Pfizer COVID-19 vaccine elicits durable specific memory T-cell response

“Catching SARS-CoV-2 in the act” – viral infection of nasal mucosa spares nerve cells

Study shows most young Australians are willing to be tested for COVID

Cuba reports 92.4 percent efficacy for 3 dose SOBERANA 02 COVID-19 vaccine

Aptamer Group and DeepVerge expand partnership for Optimer-enabled wastewater monitoring

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

Murine hepatitis virus as a surrogate for studying SARS-CoV-2 in food processing biofilms

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News